Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioNxt Solutions Inc C.BNXT

Alternate Symbol(s):  BNXTF

BioNxt Solutions Inc. is a bioscience company. The Company is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications. The Company has research and development operations in North America and Europe, with an operational focus in Germany. The Company is also focused on regulatory approval and commercialization of medical products for European markets. The Company, through its subsidiary, 3a-diagnostics GmbH, offers diagnostic products, which include COVID-19 PCR Diagnostic Kit and Peri-Implantitis Oral Biosensor.


CSE:BNXT - Post by User

Post by Franman184on Jan 28, 2021 12:36pm
226 Views
Post# 32410340

Future production facilty

Future production faciltyLets hope the project is fast tracked and revnues ramp up there after. Perhaps they are already counting on the Covid PCR test when approval in Europe and then comercialized will pay for the facility. The Sparten Covid test approved in Canada although it is PCR still requires an hour for results. 25 minutes by XPHY is a huge differance maker.  Lots of potential here but we need to see results soon. I do see the possiblity of this stock exploding under the right annoucements and lets not forget about SONA and were it went without a whole lot of factual information to justify a massive upswing in the share price in a matter of months.
<< Previous
Bullboard Posts
Next >>